At present, APL is characterized by specific t (15:17) chromosome translocation and PML-RARα gene fusion, which can be sufficiently rectified by the combined use of ATRA, anthracyclines, and arsenic trioxide (As2O3) [2,3,4]. The gene discussed is RARA; the disease is acute promyelocytic leukemia.